infect
may
caus
mortal
old
age
due
damag
immun
respons
zinc
requir
catalyst
structur
zinc
finger
regulatori
ion
involv
mani
biolog
function
includ
immun
respons
low
zinc
ion
bioavail
impair
cellmedi
immun
common
age
may
restor
physiolog
supplement
zinc
month
impact
upon
morbid
surviv
articl
review
role
zinc
immun
efficaci
age
also
describ
main
biochem
pathway
involv
role
zinc
resist
infect
age
order
better
understand
possibl
caus
immunosenesc
infect
diseas
one
major
caus
mortal
elderli
popul
decreas
cellmedi
immun
respons
pawelec
solana
zinc
may
crucial
respect
requir
catalyt
compon
enzym
structur
constitu
mani
protein
regulatori
ion
stabil
protein
prevent
free
radic
format
mill
led
recognit
zinc
lead
element
assur
correct
function
variou
tissu
organ
system
includ
poor
efficaci
convent
therapi
elderli
popul
mocchegiani
et
al
therefor
increas
zinc
bioavail
supplement
zinc
may
benefit
immunoresist
infect
age
involv
new
mechan
homeostasi
among
proinflammatori
cytokin
mt
parp
factor
zincdepend
implic
immun
effici
mocchegiani
et
al
review
consid
efficaci
zinc
suppli
immun
respons
age
acceler
age
eg
syndrom
well
main
biochem
pathway
zinc
includ
mtsnoparp
homeostasi
crucial
immunoresist
infect
age
emphasi
cytokin
age
describ
alter
age
rink
et
al
involv
mani
biochem
pathway
zinc
immunobiolog
wellinghausen
et
al
rink
et
al
mani
data
support
view
impact
zinc
immunocompet
greater
cellmedi
immun
humor
wellinghausen
et
al
particular
chemotaxi
neutrophil
monocyt
thymic
endocrin
activ
antigen
present
mhc
class
ii
molecul
natur
killer
nk
activ
cytokin
product
balanc
immun
function
affect
zinc
prasad
well
cell
mocchegiani
et
al
context
cytokin
product
peculiar
differ
synthesi
cell
accord
function
cellmedi
immun
antibodi
mediat
immun
suppress
cell
produc
ifngamma
tnfalpha
cell
produc
romagnani
wherea
cell
produc
tgfbeta
cobbold
waldman
zinc
may
directli
affect
cell
rather
cell
mean
mhccomplex
thymic
hormon
immunomodul
hormon
melatonin
thyroid
hormon
igfi
growth
hormon
mocchegiani
et
al
prasad
wherea
zinc
affect
cell
zinc
finger
dna
domain
yoo
et
al
although
specif
role
report
zinc
defici
increment
tgfbeta
observ
infect
fitzpatrick
bielefeldtohmann
well
age
relat
inflamm
mccaffrey
imbal
activ
toward
usual
age
infect
characteris
zinc
defici
prasad
therefor
imbal
may
also
includ
consider
cell
well
recent
suggest
infect
cobbold
waldman
vivo
vitro
experi
old
frasca
et
al
infect
mice
salem
et
al
show
imbal
cytokin
tgfbeta
product
cell
control
produc
macrophag
result
decreas
resist
infect
fact
synthesi
requir
develop
suppress
increas
tgfbeta
infect
mice
salem
et
al
fresno
et
al
cell
rink
et
al
fagiolo
et
al
lio
et
al
decreas
age
hand
activ
tgfbeta
import
effect
pathogen
entri
replic
persist
latenc
fitzpatrick
bielefeldtohmann
zinc
affect
product
driessen
et
al
balanc
cell
also
immunoresist
infect
may
control
zinc
turnov
alter
may
caus
decreas
resist
infect
old
age
consequ
high
mortal
supplement
zinc
may
benefit
restor
balanc
age
infect
document
elderli
peopl
cakman
et
al
nematodeinfect
mice
shi
et
al
although
data
effect
zinc
supplement
tgfbeta
avail
indirect
evid
show
resist
listeriosi
mice
increment
tnfalpha
ifngamma
decrement
tgfbeta
mab
treatment
szalay
et
al
strongli
support
possibl
involv
zinc
turnov
immunoresist
cytokin
directli
indirectli
control
zinc
turnov
fabri
et
al
relev
role
play
zinc
defici
immun
decrement
infect
age
well
document
last
decad
wellinghausen
et
al
prasad
mocchegiani
et
al
howev
dispers
data
due
great
variabl
habitat
condit
health
statu
individu
dietari
attitud
fabri
mocchegiani
lead
consid
zinc
defici
relat
singl
individu
particular
statu
rather
gener
effect
alter
zincdepend
factor
subsequ
possibl
low
zinc
ion
bioavail
immun
respons
inde
investig
report
normal
zinc
content
circul
lymphocyt
age
therefor
supplement
zinc
recommend
mislead
zinc
bound
mani
enzym
protein
mill
sinc
atom
absorpt
spectrophotometri
aa
assess
bound
unbound
zinc
real
zinc
ion
bioavail
evid
use
techniqu
mocchegiani
et
al
although
nucleotidas
may
use
examin
zinc
defici
specif
methodolog
procedur
detect
free
zinc
ion
plasma
tissu
avail
zinc
bind
enzym
develop
methodolog
procedur
test
activ
zincbound
thymulin
znft
total
thymulin
tt
activ
zincbound
znft
inact
zincunbound
ft
vitro
zinc
addit
plasma
sampl
ratio
ttat
nonsatur
fraction
thymulin
ft
zinc
ion
exist
strict
invers
correl
plasma
zinc
level
ratio
latter
good
marker
detect
zinc
ion
bioavail
consequ
real
zinc
defici
follow
cutoff
point
establish
ttat
log
mark
zinc
defici
ii
ttat
b
log
mild
zinc
defici
iii
ttat
log
normal
zinc
valu
fabri
et
al
methodolog
procedur
led
us
identifi
low
zinc
ion
bioavail
age
variou
patholog
despit
plasma
zinc
level
normal
rang
tabl
also
led
us
seek
possibl
biolog
caus
low
zinc
ion
bioavail
age
zincbind
protein
metallothionein
mt
involv
due
higher
bind
affin
kd
zinc
compar
thymulin
see
mocchegiani
et
al
howev
exclud
zincbind
protein
higher
kd
macroglobulin
increas
age
inflamm
cakman
et
al
mt
bind
preferenti
zinc
rather
copper
age
hamer
zinc
ion
bound
mt
old
liver
young
e
mocchegiani
unpublish
result
last
recent
find
laboratori
strongli
suggest
mt
sequest
zinc
constant
stress
age
induc
low
zinc
ion
bioavail
normal
immun
respons
mocchegiani
et
al
mt
may
move
protect
youngadult
danger
one
immun
respons
age
mocchegiani
et
al
hand
mt
mrna
increas
age
associ
impair
immun
function
nk
activ
also
circadian
cycl
mocchegiani
et
al
therefor
high
yr
mgdl
yr
mgdl
yr
mgdl
yr
mgdl
yr
mgdl
coeffici
invers
correl
r
ttat
plasma
zinc
level
singl
condit
calcul
also
ad
data
respect
agematch
healthi
control
youngadult
healthi
peopl
elderli
peopl
fabri
mocchegiani
rang
ttat
log
healthi
control
fabri
et
al
normal
zinc
ion
bioavail
exist
allergi
zincbound
mt
deleteri
immun
effici
age
signific
increment
alreadi
high
liver
mt
level
zinc
old
mice
mocchegiani
et
al
press
zinc
supplement
recommend
age
order
keep
immun
system
effici
mean
major
zinc
ion
bioavail
subsequ
limit
appear
infect
relaps
elderli
popul
may
occur
inde
low
zinc
bioavail
risk
factor
immun
defici
subsequ
infect
relaps
elderli
popul
mocchegiani
et
al
hand
high
mt
level
present
lymphocyt
old
peopl
yurkow
makhijani
suggest
also
measur
zinc
content
lymphocyt
may
mislead
test
zinc
ion
bioavail
follow
consider
physiolog
supplement
zinc
rda
usda
carri
age
syndrom
acceler
age
syndrom
short
period
even
know
possibl
harm
effect
zinc
toxic
immun
respons
chandra
howev
gener
consensu
supplement
zinc
syndrom
ds
physiolog
age
contradictori
data
exist
real
zinc
defici
inde
author
report
normal
slightli
reduc
zinc
content
lymphocyt
syndrom
subject
lockitch
et
al
elderli
popul
bodgen
et
al
modest
effect
immun
effici
may
also
mislead
despit
plasma
zinc
level
normal
rang
age
ds
age
fabri
et
al
ttat
ratio
log
tabl
suggest
presenc
low
zinc
ion
bioavail
condit
agreement
other
stabil
et
al
lesourd
physiolog
supplement
zinc
lozeng
mg
zn
day
one
two
month
elderli
popul
ds
restor
immun
respons
decreas
oxid
damag
modif
copper
level
fabri
et
al
reduct
infecti
episod
ds
elderli
subject
occur
zinc
treatment
mainten
good
health
better
cognit
perform
also
month
yr
followup
fabri
et
al
johnson
porter
fort
et
al
mocchegiani
et
al
similarli
physiolog
zinc
treatment
mg
zn
day
drink
water
presenesc
mice
age
month
restor
immun
respons
reduct
mortal
infect
mycoplasma
pulmoni
coronaviru
murini
consequ
signific
prolong
surviv
compar
normal
mice
mocchegiani
et
al
mocchegiani
et
al
moreov
supplement
zinc
restor
balanc
elderli
popul
cakman
et
al
also
interest
note
supplement
zinc
benefit
restor
immun
effici
subsequ
signific
reduct
infect
relaps
also
youngadult
peopl
affect
variou
patholog
condit
tabl
therefor
zinc
crucial
maintain
normal
immun
effici
infect
entir
life
span
consequ
lack
zinc
ion
bioavail
pivot
better
understand
possibl
caus
immunosenesc
benefici
effect
physiolog
zinc
supplement
immun
system
must
howev
relat
competit
phenomena
zinc
sever
cation
cadmium
lead
calcium
iron
manganes
copper
benefici
effect
zinc
amelior
toxic
cadmium
lead
accentu
zinc
defici
administr
calcium
phytat
product
hypocupremia
excess
zinc
intak
human
anim
model
exampl
competit
phenomena
hill
competit
occur
ion
similar
valenc
shell
electron
structur
therefor
antagonist
biolog
copper
zinc
cadmium
similar
orbit
configur
coordin
number
shown
interact
hurley
et
al
interact
occur
zinc
iron
fe
level
cysteinehistidin
ligand
format
iron
zinc
finger
protein
prasad
cours
excess
iron
preferenti
bind
iron
zinc
metal
freeprotein
occur
bind
iron
result
howev
loss
nucleic
acidbind
activ
klausner
et
al
excess
zinc
well
zinc
defici
impair
dnaprotein
interact
zinc
finger
domain
cognat
dna
target
site
thiesen
bach
result
product
transcript
factor
tfiiia
relev
cell
prolifer
differenti
impair
thiesen
bach
impair
zinc
finger
dna
domain
occur
excess
defici
copper
thiesen
bach
reinforc
notion
relev
interact
zinc
copper
gener
also
metal
effici
immun
chandra
thu
limit
rang
bioavail
exist
metal
may
narrow
broad
other
inde
benefici
effect
zinc
strictli
depend
dose
length
treatment
zinc
accumul
imbal
zinctocopp
ratio
may
occur
despit
low
dose
zinc
fabri
mocchegiani
thu
harm
side
effect
cardiovascular
system
brain
may
appear
increas
low
densiti
lipoprotein
cholesterol
fosmir
neural
celldeath
kim
et
al
therefor
caution
zinc
supplement
warrant
success
treatment
avoid
undesir
harm
side
effect
zinc
supplement
must
exceed
time
rdaday
short
period
month
period
cycl
treatment
interfer
copper
absorpt
fabri
mocchegiani
zinc
picolin
form
best
supplement
wapnir
et
al
mechan
zinc
may
affect
immun
system
multifacet
due
zinc
widespread
action
differ
enzym
peptid
transcript
factor
cytokin
involv
variou
physiolog
step
immun
develop
reactiv
main
biochem
pathway
zinc
possibl
relev
immunoresist
infect
age
summaris
tabl
zinc
directli
influenc
immun
cell
mean
multipl
enzym
level
replic
transcript
includ
dna
rna
polymeras
thymidinekinas
termin
deoxyribonucleotidyl
transferas
ornithin
decarboxylas
enzym
zincdepend
involv
mitosi
chester
zincdepend
enzym
nucleosid
phosphorylas
nucleotidas
protein
kinas
c
pkc
directli
involv
zinc
affect
immun
system
presenc
lymphocyt
membran
prasad
thu
zinc
affect
membran
stabil
compet
thiol
influenc
peroxid
damag
bettger
odel
addit
zinc
protect
oxid
stress
proinflammatori
cytokin
transcript
factor
nfkb
activ
hennig
et
al
occur
transcript
factor
nfkb
well
mani
other
involv
cell
prolifer
prevent
apoptosi
ring
tfiiia
bte
zeb
contain
zinc
fingerlik
domain
influenc
chang
intracellular
pool
zinc
shankar
prasad
rink
gabriel
press
moreov
zinc
play
role
tlymphocyt
activ
mean
tyrosin
kinas
lck
essenti
protein
earli
step
activ
zinc
stimul
autophosphoryl
tyrosin
residu
lck
subsequ
phosphoryl
antigen
receptor
complex
involv
pernel
et
al
reduct
lck
activ
age
shankar
prasad
could
reduc
abil
chemokin
receptor
tcell
bind
cc
cxc
famili
chemokin
would
result
reduct
migrat
naiv
tcell
inflammatori
site
subsequ
format
prime
memori
tcell
seem
reduc
age
mice
borghesi
nicoletti
contrast
normal
zinc
turnov
induc
lck
inhibit
viral
penetr
phosphoryl
membran
protein
via
pkc
pasternak
relev
pathway
zinc
affect
immun
system
relat
discoveri
apoptosi
prevent
zinc
apoptosi
mechan
involv
decreas
immun
respons
age
infect
monti
et
al
shankar
prasad
low
zinc
bioavail
usual
event
condit
fabri
mocchegiani
although
apoptosi
prevent
depend
zinc
dose
fraker
telford
mechan
zinc
prevent
apoptosi
appli
multipl
level
inhibit
ca
mg
dna
endonucleas
activ
activ
nuclear
factor
nfkb
inhibit
increas
ratio
blockad
ligand
bind
glucocorticoid
receptor
studi
zinc
prevent
apoptosi
age
especi
endonucleas
enzym
activ
fraker
telford
blockad
ligand
bind
glucocorticoid
receptor
provinciali
et
al
anoth
direct
pathway
relat
discoveri
zinc
requir
biolog
activ
thymic
hormon
call
tabl
main
biochem
pathway
zinc
relev
immunoresist
infect
age
direct
effect
dnarna
polymeras
activ
thymidinekinas
activ
termin
deoxyribonucleotidyl
transferas
activ
ornithin
decarboxylas
activ
nucleotidas
activ
protein
kinasec
activ
membran
stabil
compet
thiol
transcript
factor
activ
nfkb
apoptosi
prevent
thymulin
activ
znft
balanc
paradigm
subsequ
cytokin
product
mhc
class
ii
restrict
activ
lck
autophosphoryl
endocrin
cell
activ
pineal
gland
thyroid
gland
adenohypophysi
bcell
pancrea
hormon
receptor
superfamili
activ
melatonin
growth
hormon
nerv
growth
factor
insulin
igfi
thyroid
hormon
metallothioneinsnitricoxideparp
homeostasi
see
specif
refer
shankar
prasad
rink
gabriel
press
mocchegiani
et
al
fraker
telford
thymulin
znft
essenti
tcell
matur
differenti
cytokin
product
natur
killer
cell
activ
consequ
effici
entir
immun
system
host
defenc
dardenn
et
al
mocchegiani
et
al
consequ
correct
balanc
cytokin
occur
demonstr
elderli
cakman
et
al
rink
et
al
paradigm
may
also
includ
cell
control
fresno
et
al
turn
decreas
age
affect
zinc
driessen
et
al
thymulin
hadden
among
indirect
pathway
action
immunomodul
hormon
melatonin
growth
hormon
thyroid
hormon
insulinlik
growth
recent
propos
hormon
also
affect
immun
mean
zinc
pool
mocchegiani
et
al
b
turn
requir
activ
nuclear
hormon
receptor
fabri
et
al
indirect
pathway
zinc
antioxid
bray
bettger
homeostasi
among
zincbound
mt
parp
recent
propos
relat
presenc
massiv
constant
stress
age
mocchegiani
et
al
strict
link
mt
parp
turn
control
proinflammatori
cytokin
zinc
turnov
see
mocchegiani
et
al
alter
one
step
homeostasi
may
final
divert
parp
toward
celldeath
rather
dnarepair
inde
zincbound
mt
increas
age
acquir
danger
role
immun
also
augment
age
capanni
et
al
final
result
protect
role
oxid
damag
mcbride
et
al
prevent
apoptosi
induc
parp
pieper
et
al
contrast
moder
stress
normal
zinc
bioavail
trigger
parp
dna
repair
youngadult
dantzer
et
al
therefor
alter
zinc
turnov
might
primu
moven
decreas
immunoresist
infect
age
mean
alter
biochem
homeostasi
via
proinflammatori
cytokin
mocchegiani
et
al
supplement
zinc
age
may
correct
defect
inde
increas
mt
mrna
caus
zinc
cousin
leeambros
affect
alreadi
high
liver
mt
level
mocchegiani
et
al
press
suggest
mt
satur
preexist
zinc
ion
age
increas
mt
mrna
act
reserv
mt
product
prompt
respons
continu
oxid
damag
mocchegiani
et
al
mocchegiani
et
al
press
normal
affect
parp
activ
occur
youngadult
age
addit
mt
regain
origin
role
protect
releas
zinc
superoxid
dismutas
sod
maret
et
al
decreas
age
subsequ
cellular
oxid
damag
mocchegiani
et
al
analag
phenomenon
regain
protect
occur
increas
macroglobulin
cancer
result
zinc
supplement
mocchegiani
et
al
therefor
suppli
zinc
age
benefit
either
regain
mt
role
protect
induc
zinc
ion
bioavail
immun
effici
normal
activ
recent
suggest
sprietsma
protect
youngadult
age
danger
old
age
final
result
dnarepair
celldeath
parp
respect
strictli
depend
oxid
nitros
stress
statu
moder
young
age
massiv
old
age
mocchegiani
et
al
hatch
line
old
age
current
investig
laboratori
zinc
requir
catalyt
structur
regulatori
ion
enzym
protein
transcript
factor
therefor
key
trace
element
mani
bodi
homeostat
mechan
includ
immun
respons
low
zinc
ion
bioavail
result
limit
immunoresist
infect
age
physiolog
supplement
zinc
month
restor
immun
respons
therebi
reduc
incid
infect
consequ
prolong
surviv
ame
use
may
relev
poor
develop
countri
thank
low
cost
zinc
infect
incid
high
sazaw
et
al
black
among
biochem
pathway
zinc
affect
immun
system
zincbound
mt
parp
homeostasi
via
proinflammatori
cytokin
also
involv
proinflammatori
cytokin
mt
increas
age
sinc
activ
parp
doubl
role
dnarepair
celldeath
depend
level
oxid
stress
massiv
age
capanni
et
al
parp
activ
may
address
toward
celldeath
rather
dnarepair
pieper
et
al
fig
zinc
supplement
age
might
nonetheless
restor
dna
repair
function
parp
last
point
investig
moreov
normal
parp
activ
implic
healthi
longev
muira
et
al
debenedicti
et
al
wingrov
ofarrel
increas
mt
liver
atroph
thymu
old
mice
mocchegiani
et
al
normal
product
may
also
involv
facilit
healthi
longev
polymorph
within
human
gene
encod
synthas
parp
mt
exist
martin
et
al
west
et
al
data
howev
fragmentari
limit
factor
alon
genet
studi
must
perform
context
gene
schachter
et
al
therefor
genet
studi
homeostasi
total
might
provid
insight
possibl
biolog
genet
marker
immunosenesc
genet
studi
current
progress
laboratori
